@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/D05BB02> a ns1:ATCConcept ;
    skos:notation "D05BB02" ;
    skos:prefLabel "Acitretin"@cs,
        "Acitretin"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0026177> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001866>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003529> ;
    ns1:description "An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.     "@en ;
    ns1:hasMechanismOfAction <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000009915> ;
    ns1:hasMedicinalProduct <http://linked.opendata.cz/resource/sukl/medicinal-product/NEOTIGASON-10-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/NEOTIGASON-25-MG> ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0011969> ;
    ns1:mayTreat <http://linked.opendata.cz/resource/ndfrt/disease/N0000002526> ;
    ns1:title "Acitretin"@cs,
        "Acitretin"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0011969> a ns1:PharmacologicalAction ;
    ns1:description "Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.     "@en ;
    ns1:title "Keratolytika"@cs,
        "Keratolytic agents"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001866> a ns1:DiseaseOrFinding ;
    ns1:description "Pathological processes of the LIVER.     "@en ;
    ns1:title "Nemoci jater"@cs,
        "Liver diseases"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002526> a ns1:DiseaseOrFinding ;
    ns1:description "A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.     "@en ;
    ns1:title "Psoriáza"@cs,
        "Psoriasis"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003529> a ns1:DiseaseOrFinding ;
    ns1:description "A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.     "@en ;
    ns1:title "Selhání ledvin"@cs,
        "Kidney failure"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000009915> a ns1:MechanismOfAction ;
    ns1:title "Unknown Cellular or Molecular Interaction"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/NEOTIGASON-10-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/D05BB02> ;
    ns1:title "NEOTIGASON 10 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/NEOTIGASON-25-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/D05BB02> ;
    ns1:title "NEOTIGASON 25 MG"@cs .


